HAL vs ORKA · P/E 9.3, $19.05B cap vs $4.27B cap
Halliburton Company (HAL) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the HAL and ORKA stock pages for the full models.
Not investment advice.